Alfa-1 antitrypsin after one year COVID-19 infection
B. Jimenez Rodriguez (Granada, Spain), J. Ceballos Gutiérrez (Murcia, Spain), E. Triviño Ibañez (Granada, Spain), J. Gutiérrez Fernández (Granada, Spain), A. Romero Ortiz (Granada, Spain), C. Morales García (Granada, Spain)
Source: International Congress 2022 – After COVID
Session: After COVID
Session type: Thematic Poster
Number: 3340
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Jimenez Rodriguez (Granada, Spain), J. Ceballos Gutiérrez (Murcia, Spain), E. Triviño Ibañez (Granada, Spain), J. Gutiérrez Fernández (Granada, Spain), A. Romero Ortiz (Granada, Spain), C. Morales García (Granada, Spain). Alfa-1 antitrypsin after one year COVID-19 infection. 3340
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|